Genetic insights into PHARC syndrome: identification of a novel frameshift mutation in ABHD12.
ABHD12
Ataxia
Cataract
Endocannabinoid
Hearing loss
Neurodegenerative
PHARC
Polyneuropathy
Retinitis pigmentosa
Whole-exome sequencing
Journal
BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628
Informations de publication
Date de publication:
06 10 2023
06 10 2023
Historique:
received:
08
04
2023
accepted:
02
10
2023
medline:
2
11
2023
pubmed:
7
10
2023
entrez:
6
10
2023
Statut:
epublish
Résumé
Mutations in ABHD12 (OMIM: 613,599) are associated with polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC) syndrome (OMIM: 612674), which is a rare autosomal recessive neurodegenerative disease. PHARC syndrome is easily misdiagnosed as other neurologic disorders, such as retinitis pigmentosa, Charcot-Marie-Tooth disease, and Refsum disease, due to phenotype variability and slow progression. This paper presents a novel mutation in ABHD12 in two affected siblings with PHARC syndrome phenotypes. In addition, we summarize genotype-phenotype information of the previously reported patients with ABHD12 mutation. Following a thorough medical evaluation, whole-exome sequencing was done on the proband to look for potential genetic causes. This was followed by confirmation of identified variant in the proband and segregation analysis in the family by Sanger sequencing. The variants were interpreted based on the American College of Medical Genetics and Genomics (ACMG) guidelines. A novel pathogenic homozygous frameshift variant, NM_001042472.3:c.601dup, p.(Val201GlyfsTer4), was identified in exon 6 of ABHD12 (ACMG criteria: PVS1 and PM2, PM1, PM4, PP3, and PP4). Through Sanger sequencing, we showed that this variant is co-segregated with the disease in the family. Further medical evaluations confirmed the compatibility of the patients' phenotype with PHARC syndrome. Our findings expand the spectrum of mutations in the ABHD12 and emphasize the significance of multidisciplinary diagnostic collaboration among clinicians and geneticists to solve the differential diagnosis of related disorders. Moreover, a summary based on mutations found so far in the ABHD12 gene did not suggest a clear genotype-phenotype correlation for PHARC syndrome.
Sections du résumé
BACKGROUND
Mutations in ABHD12 (OMIM: 613,599) are associated with polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC) syndrome (OMIM: 612674), which is a rare autosomal recessive neurodegenerative disease. PHARC syndrome is easily misdiagnosed as other neurologic disorders, such as retinitis pigmentosa, Charcot-Marie-Tooth disease, and Refsum disease, due to phenotype variability and slow progression. This paper presents a novel mutation in ABHD12 in two affected siblings with PHARC syndrome phenotypes. In addition, we summarize genotype-phenotype information of the previously reported patients with ABHD12 mutation.
METHODS
Following a thorough medical evaluation, whole-exome sequencing was done on the proband to look for potential genetic causes. This was followed by confirmation of identified variant in the proband and segregation analysis in the family by Sanger sequencing. The variants were interpreted based on the American College of Medical Genetics and Genomics (ACMG) guidelines.
RESULTS
A novel pathogenic homozygous frameshift variant, NM_001042472.3:c.601dup, p.(Val201GlyfsTer4), was identified in exon 6 of ABHD12 (ACMG criteria: PVS1 and PM2, PM1, PM4, PP3, and PP4). Through Sanger sequencing, we showed that this variant is co-segregated with the disease in the family. Further medical evaluations confirmed the compatibility of the patients' phenotype with PHARC syndrome.
CONCLUSIONS
Our findings expand the spectrum of mutations in the ABHD12 and emphasize the significance of multidisciplinary diagnostic collaboration among clinicians and geneticists to solve the differential diagnosis of related disorders. Moreover, a summary based on mutations found so far in the ABHD12 gene did not suggest a clear genotype-phenotype correlation for PHARC syndrome.
Identifiants
pubmed: 37803361
doi: 10.1186/s12920-023-01682-w
pii: 10.1186/s12920-023-01682-w
pmc: PMC10557151
doi:
Substances chimiques
ABHD12 protein, human
EC 3.1.1.23
Monoacylglycerol Lipases
EC 3.1.1.23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
235Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531
pubmed: 36408920
Otol Neurotol. 2022 Dec 1;43(10):1125-1136
pubmed: 36190904
Indian J Ophthalmol. 2021 Jul;69(7):1753-1757
pubmed: 34146021
Nucleic Acids Res. 2000 Jan 1;28(1):352-5
pubmed: 10592272
Curr Protoc Bioinformatics. 2012 Sep;Chapter 1:1.13.1-1.13.20
pubmed: 22948725
J Peripher Nerv Syst. 2017 Jun;22(2):77-84
pubmed: 28448692
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Eur J Neurosci. 2021 Nov;54(10):7442-7457
pubmed: 34727579
Ir J Med Sci. 2022 Aug;191(4):1877-1890
pubmed: 34374940
Clin Interv Aging. 2017 Mar 03;12:459-465
pubmed: 28424544
Orphanet J Rare Dis. 2012 Sep 02;7:59
pubmed: 22938382
Ann Otol Rhinol Laryngol. 2015 May;124 Suppl 1:77S-83S
pubmed: 25743180
Am J Hum Genet. 2010 Sep 10;87(3):410-7
pubmed: 20797687
Bioinformatics. 2018 Jun 1;34(11):1937-1938
pubmed: 29360956
Arch Ophthalmol. 2006 Oct;124(10):1465-70
pubmed: 17030715
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Acta Physiol (Oxf). 2012 Feb;204(2):267-76
pubmed: 21418147
Hum Mutat. 2013 Dec;34(12):1672-8
pubmed: 24027063
Ophthalmic Genet. 2021 Dec;42(6):664-673
pubmed: 34223797
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Fetal Pediatr Pathol. 2020 Feb;39(1):1-12
pubmed: 31215297
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
Nucleic Acids Res. 2020 Jan 8;48(D1):D835-D844
pubmed: 31777943
Arch Iran Med. 2012 Jan;15(1):49-51
pubmed: 22208444
Neurobiol Dis. 2017 Feb;98:36-51
pubmed: 27890673
Hum Mutat. 2019 Aug;40(8):1030-1038
pubmed: 31116477
Hum Mutat. 2019 Nov;40(11):1968-1984
pubmed: 31343797
Arch Ophthalmol. 2006 Jan;124(1):95-101
pubmed: 16401790
Nat Chem Biol. 2018 Dec;14(12):1099-1108
pubmed: 30420694
Genet Med. 2010 Aug;12(8):512-6
pubmed: 20613545
Genes (Basel). 2021 Sep 11;12(9):
pubmed: 34573385
Pharmacol Rev. 2006 Sep;58(3):389-462
pubmed: 16968947
J Lipid Res. 2012 Nov;53(11):2413-24
pubmed: 22969151
Mov Disord Clin Pract. 2021 Jul 09;8(6):977-979
pubmed: 34405110
J Neurol Sci. 2018 Apr 15;387:134-138
pubmed: 29571850
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Am J Hum Genet. 2018 Oct 4;103(4):484-497
pubmed: 30245029
Nucleic Acids Res. 2017 Jan 4;45(D1):D865-D876
pubmed: 27899602
Ophthalmic Physiol Opt. 2012 May;32(3):242-51
pubmed: 22348651
Ophthalmology. 2014 Aug;121(8):1620-7
pubmed: 24697911
J Public Health (Oxf). 2016 Jun;38(2):e21-8
pubmed: 26177816
Hum Mutat. 2018 Nov;39(11):1593-1613
pubmed: 30311386
J Peripher Nerv Syst. 2020 Jun;25(2):112-116
pubmed: 32077159
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
BMC Med Genomics. 2022 Jun 16;15(1):133
pubmed: 35710363
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1500-5
pubmed: 23297193
Gene. 2019 Jul 1;704:113-120
pubmed: 30974196